Patents by Inventor Marcel R. Kling

Marcel R. Kling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-containing heterocyclic compounds
    Patent number: 9499560
    Abstract: The present invention relates to N-containing heterocyclic compounds that are inhibitors of protein kinases including JAK kinases. In particular, the compounds are selective for JAK1, JAK2, JAK3 or TYK2 kinases and combinations thereof such as JAK1 and JAK2. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases; and vascular diseases.
    Type: Grant
    Filed: May 15, 2014
    Date of Patent: November 22, 2016
    Assignee: YM BIOSCIENCES AUSTRALIA PTY LTD
    Inventors: David G. Bourke, Christopher J. Burns, Anthony N. Cuzzupe, John T. Feutrill, Marcel R. Kling, Tracy L. Nero
  • N-CONTAINING HETEROCYCLIC COMPOUNDS
    Publication number: 20150018350
    Abstract: The present invention relates to N-containing heterocyclic compounds that are inhibitors of protein kinases including JAK kinases. In particular, the compounds are selective for JAK1, JAK2, JAK3 or TYK2 kinases and combinations thereof such as JAK1 and JAK2. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases; and vascular diseases.
    Type: Application
    Filed: May 15, 2014
    Publication date: January 15, 2015
    Inventors: David G. Bourke, Christopher J. Burns, Anthony N. Cuzzupe, John T. Feutrill, Marcel R. Kling, Tracy L. Nero